Wolfgang E. Schmidt

17.9k total citations · 2 hit papers
280 papers, 13.2k citations indexed

About

Wolfgang E. Schmidt is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Wolfgang E. Schmidt has authored 280 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Surgery, 99 papers in Molecular Biology and 81 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Wolfgang E. Schmidt's work include Neuropeptides and Animal Physiology (74 papers), Diabetes Treatment and Management (60 papers) and Pancreatic function and diabetes (43 papers). Wolfgang E. Schmidt is often cited by papers focused on Neuropeptides and Animal Physiology (74 papers), Diabetes Treatment and Management (60 papers) and Pancreatic function and diabetes (43 papers). Wolfgang E. Schmidt collaborates with scholars based in Germany, Denmark and United States. Wolfgang E. Schmidt's co-authors include Juris J. Meier, Michael A. Nauck, Jens J. Holst, Baptist Gallwitz, Baptist Gallwitz, Rolf Mentlein, W. Creutzfeldt, John B. Buse, Ulrich R. Fölsch and Julio Rosenstock and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Wolfgang E. Schmidt

275 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

2009 1.2k citations John B. Buse, Giorgio Sesti et al. profile →
Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1993 966 citations Rolf Mentlein, Baptist Gallwitz et al. profile →

Peers

Countries citing papers authored by Wolfgang E. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Wolfgang E. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang E. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang E. Schmidt more than expected).

Fields of papers citing papers by Wolfgang E. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang E. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang E. Schmidt. The network helps show where Wolfgang E. Schmidt may publish in the future.

Co-authorship network of co-authors of Wolfgang E. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang E. Schmidt. A scholar is included among the top collaborators of Wolfgang E. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang E. Schmidt. Wolfgang E. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver Scores in the Prognostication of COVID-19 Patients 2025 ·Viruses ·Thilo Gambichler, Dorothea König, (unknown), Laura Susok, Wolfgang E. Schmidt, Nessr Abu Rached	0
2	A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality 2024 ·Viruses ·Thilo Gambichler, (unknown), (unknown), (unknown), Marina Skrygan, Laura Susok, Jürgen C. Becker, (unknown), Wolfgang E. Schmidt, Anke Reinacher‐Schick	2
3	Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats 2023 ·Frontiers in Cardiovascular Medicine ·Saltanat Zhazykbayeva, (unknown), Melissa Herwig, Heidi Budde, Árṕad Kov́acs, Hans Georg Mannherz, Ibrahim El‐Battrawy, Attila Tóth, Wolfgang E. Schmidt, Andreas Mügge, Nazha Hamdani	6
4	Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients 2022 ·The Journal of Infectious Diseases ·Toni Luise Meister, (unknown), (unknown), Yannick Brüggemann, Natalie Heinen, Günter Kampf, Daniel Tödt, Huu Phuc Nguyen, Jörg Steinmann, Wolfgang E. Schmidt, Eike Steinmann, Daniel R. Quast, Stephanie Pfaender	20
5	Whipple’s disease – a rare and challenging complication in a patient with Crohn’s disease 2022 ·Zeitschrift für Gastroenterologie ·Kerem Bulut, Antoaneta A. Markova, Ali Canbay, Wolfgang E. Schmidt, Alişan Kahraman	2
6	Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study 2017 ·Annals of Oncology ·Beate Schultheis, Dirk Reuter, M. Ebert, Jens T. Siveke, Andrea Kerkhoff, Wolfgang E. Berdel, Ralf‐Dieter Hofheinz, Dirk Behringer, Wolfgang E. Schmidt, Erdem Göker, Sara De Dosso, Michael Kneba, Şuayib Yalçın, Friedrich Overkamp, Frank Schlegel, (unknown), Robert Rohrberg, (unknown), Michael Bulitta, Dirk Strumberg	97
7	Patient‐reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open‐label study 2011 ·Diabetic Medicine ·Wolfgang E. Schmidt, Jens Sandahl Christiansen, Mette Hammer, Marcin Zychma, John B. Buse	30
8	High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program 2010 ·Diabetologia ·Matthew J. Armstrong, A Falahati, (unknown), Wolfgang E. Schmidt, S Gough, Philip N. Newsome	1
9	High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program 2010 ·Diabetes ·Matthew J. Armstrong, A Falahati, Oscar Ö. Braun, Wolfgang E. Schmidt, S Gough, Philip N. Newsome	4
10	Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss 2009 ·Diabetologia ·Wolfgang E. Schmidt, Stephen Gough, Sten Madsbad, Bernard Zinman, A Falahati, Anders Toft, Giorgio Sesti	5
11	Probiotics Regulate the Expression of COX-2 in Intestinal Epithelial Cells 2008 ·Nutrition and Cancer ·Jan‐Michel Otte, (unknown), Stephan Brand, (unknown), Wolfgang E. Schmidt, Frank Schmitz	60
12	The glucagon-like peptide-1 metabolite GLP-1-(9–36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·Juris J. Meier, (unknown), Michael A. Nauck, Oliver Götze, Frank Schmitz, Carolyn F. Deacon, Baptist Gallwitz, Wolfgang E. Schmidt, Jens J. Holst	85
13	Sildenafil improves hemodynamic parameters in COPD—an investigation of six patients 2005 ·Pulmonary Pharmacology & Therapeutics ·(unknown), Marina Skrygan, Wolfgang E. Schmidt, Andreas Bastian	64
14	Effekte von Diclofenac und selektiven Cyclooxygenase-(COX-)2-Inhibitoren auf die Prostaglandinfreisetzung aus entz�ndetem Bursa-subacromialis-Gewebe von Patienten mit Subakromialsyndrom in vitro 2004 ·Der Orthopäde ·(unknown), R. H. Wittenberg, (unknown), (unknown), Wolfgang E. Schmidt, B. M. Peskar, M. Wiese, (unknown), R. Willburger	1
15	Galanin in pituitary adenomas 2003 ·Regulatory Peptides ·Eva Grenbäck, Per Bjellerup, (unknown), Lars Lundblad, A. Änggård, K. Ericson, (unknown), Marc Landry, Wolfgang E. Schmidt, Tomas Hökfelt, Anna‐Lena Hulting	21
16	Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer 2003 ·Cancer Letters ·Honggang Yu, Jianying Li, Yanning Yang, Hesheng Luo, Jie‐Ping Yu, Juris J. Meier, Henning Schrader, Andreas Bastian, Wolfgang E. Schmidt, Frank Schmitz	34
17	GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro 2000 ·Regulatory Peptides ·Baptist Gallwitz, (unknown), Corinna Morys‐Wortmann, Rolf Mentlein, Erhard Siegel, Wolfgang E. Schmidt	55
18	Human PACAP Response Gene 1 (p22/PRG1) 1999 ·Pancreas ·H. Schäfer, (unknown), Anna Trauzold, Matthias Banasch, Wolfgang E. Schmidt	32
19	Light and electron microscopical immunocytochemical localization of pancreastatin-like immunoreactivity in porcine tissues 1990 ·Histochemistry and Cell Biology ·R. Lamberts, Wolfgang E. Schmidt, W. Creutzfeldt	29
20	[Chemical modification and catalytic activity of carbonate-hydro-lyase B from bovine erythrocytes. Modification of arginine, histidine, lysine, tyrosine and tryptophan]. 1971 ·PubMed ·S. Nees, Wolfgang E. Schmidt, F Schneider	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact